Literature DB >> 1769691

Vitamin D3 binding protein required for in vitro activation of macrophages after alkylglycerol treatment of mouse peritoneal cells.

N Yamamoto1, S Homma, J G Haddad, M A Kowalski.   

Abstract

In vitro treatment of peritoneal cells with dodecylglycerol (DDG) in 10% foetal calf serum (FCS) supplemented medium RPMI-1640 results in a greatly enhanced Fc receptor-mediated phagocytic activity of macrophages. This macrophage activation process requires a serum factor in the alpha 2-globulin fraction. When mouse peritoneal cells were treated with 50 ng DDG/ml in a serum-free 0.1% egg albumin-supplemented medium RPMI-1640 (EA medium) for 30 min and cultured in EA medium containing electrophoretically fractionated alpha 2-globulin for 3 hr, a markedly enhanced activation of macrophages was observed. To improve fractionation of alpha 2-globulin, FCS was first precipitated with 50% saturated ammonium sulphate and then the supernatant electrophoretically fractionated. The resultant alpha 2-globulin fraction was unable to support activation of macrophages. Vitamin D3 binding protein (DBP) of the alpha 2-globulin fraction is known to be precipitable by 50% saturated ammonium sulphate. When human alpha 2-globulin was treated with antiserum against human DBP and used in a medium for cultivation of DDG-treated peritoneal cells, no significant activation of macrophages was observed. Cultivation of DDG-treated peritoneal cells in a medium containing a low concentration of purified human DBP (group specific component, Gc) produced a greatly enhanced ingestion activity of macrophages. Purified human Gc protein, when used in an EA medium for step-wise cultivation of DDG-treated B and untreated T cells, was efficiently converted to a macrophage-activating factor.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1769691      PMCID: PMC1384634     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  14 in total

1.  Identification of the serum factor required for in vitro activation of macrophages. Role of vitamin D3-binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages.

Authors:  N Yamamoto; S Homma; I Millman
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

2.  Post-translational heterogeneity of the human vitamin D-binding protein (group-specific component).

Authors:  D H Coppenhaver; N P Sollenne; B H Bowman
Journal:  Arch Biochem Biophys       Date:  1983-10-01       Impact factor: 4.013

3.  Plasmacytomas and murine immunoglobulins.

Authors:  S J Smith-Gill; F D Finkelman; M Potter
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

4.  Activation process of macrophages after in vitro treatment of mouse lymphocytes with dodecylglycerol.

Authors:  S Homma; N Yamamoto
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

5.  Activation of peritoneal macrophages by lysophosphatidylcholine.

Authors:  B Z Ngwenya; N Yamamoto
Journal:  Biochim Biophys Acta       Date:  1985-03-29

6.  Rat vitamin D binding protein. Determination of the full-length primary structure from cloned cDNA.

Authors:  N E Cooke
Journal:  J Biol Chem       Date:  1986-03-05       Impact factor: 5.157

7.  Activation of mouse macrophages by alkylglycerols, inflammation products of cancerous tissues.

Authors:  N Yamamoto; D A St Claire; S Homma; B Z Ngwenya
Journal:  Cancer Res       Date:  1988-11-01       Impact factor: 12.701

8.  Actin affinity chromatography in the purification of human, avian and other mammalian plasma proteins binding vitamin D and its metabolites (Gc globulins).

Authors:  J G Haddad; M A Kowalski; J W Sanger
Journal:  Biochem J       Date:  1984-03-15       Impact factor: 3.857

9.  Activation of mouse peritoneal macrophages by lysophospholipids and ether derivatives of neutral lipids and phospholipids.

Authors:  N Yamamoto; B Z Ngwenya
Journal:  Cancer Res       Date:  1987-04-15       Impact factor: 12.701

10.  Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation.

Authors:  C Bianco; F M Griffin; S C Silverstein
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

View more
  8 in total

1.  Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein.

Authors:  F F Safadi; P Thornton; H Magiera; B W Hollis; M Gentile; J G Haddad; S A Liebhaber; N E Cooke
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

2.  Inhibitory effect of vitamin D-binding protein-derived macrophage activating factor on DMBA-induced hamster cheek pouch carcinogenesis and its derived carcinoma cell line.

Authors:  Yukiyo Toyohara; Susumu Hashitani; Hiromitsu Kishimoto; Kazuma Noguchi; Nobuto Yamamoto; Masahiro Urade
Journal:  Oncol Lett       Date:  2011-05-13       Impact factor: 2.967

Review 3.  An update on the therapeutic role of alkylglycerols.

Authors:  Tommaso Iannitti; Beniamino Palmieri
Journal:  Mar Drugs       Date:  2010-08-05       Impact factor: 5.118

4.  Participation of serum proteins in the inflammation-primed activation of macrophages.

Authors:  N Yamamoto; N P Willett; D D Lindsay
Journal:  Inflammation       Date:  1994-06       Impact factor: 4.092

5.  Regulation of inflammation-primed activation of macrophages by two serum factors, vitamin D3-binding protein and albumin.

Authors:  N Yamamoto; R Kumashiro; M Yamamoto; N P Willett; D D Lindsay
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

6.  Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.

Authors:  Gautam Mondal; Ashish Saroha; Partha Pratim Bose; B P Chatterjee
Journal:  Glycoconj J       Date:  2016-03-31       Impact factor: 2.916

7.  Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF.

Authors:  Nobuto Yamamoto; Hirofumi Suyama; Nobuyuki Yamamoto
Journal:  Transl Oncol       Date:  2008-07       Impact factor: 4.243

8.  An insight into the changes in human plasma proteome on adaptation to hypobaric hypoxia.

Authors:  Yasmin Ahmad; Narendra K Sharma; Iti Garg; Mohammad Faiz Ahmad; Manish Sharma; Kalpana Bhargava
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.